Although respiratory syncytial virus (RSV) has been a high priority for vaccine development for over 50 years now, still no vaccine is available and none has yet demonstrated sufficient promise to move to licensure. The success of RSV immune prophylaxis and the availability of ever more powerful tools to study the immune response and pathogenesis of disease, combined with the ability to construct a wide variety of vaccines using different vaccine...
De Challenges and Opportunities for Respiratory Syncytial Virus Vaccines is een populaire optie voor Medische microbiologie & Virologie. Esy heeft 1 prijs gevonden, de goedkoopste keuze is volgens ons Bol, maar bekijk de andere aanbieders om het zeker te weten. Links openen in een nieuwe tabblad. Bekijk hier onder de product specificaties. Meer product informatie beschikbaar bij Bol.
Challenges and Opportunities for Respiratory Syncytial Virus Vaccines is onder andere te koop bij: Bol. Esy raadt altijd aan om meerdere aanbieders te bekijken om geen last minute deals mis te lopen.
The nucleotide sequence of the gene from which messenger RNA mole- cules are transcribed is in a form that can be translated by cellular ribosomes into the amino acid sequence of a particular polypept...
Naar goedkoopste shop Vergelijk meer shopsAntiviral chemotherapy has come of age, and, after an initial slow pro gress, the development of new antiviral agents has proceeded at a more rapid pace and the perspectives for their clinical use ha...
Naar goedkoopste shop Vergelijk meer shops